GERMAN company BioNTech aims to produce two billion vaccine doses in 2021, significantly raising the production forecast for its Covid-19 vaccine for this year. The company is now assuming a production capacity of two billion vaccine doses, the company announced on Monday (January 11) in an investor presentation. So far, BioNTech and its US partner […]
The post BioNTech Aims To Produce Two Billion Vaccine Doses in 2021 appeared first on Euro Weekly News Spain.
